Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 AUD | +4.35% | 0.00% | -31.43% |
03:57am | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.43% | 13.14M | |
+10.14% | 114B | |
+12.57% | 107B | |
-5.59% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.84% | 17.51B | |
-39.36% | 17.17B | |
+6.72% | 14.14B | |
+34.28% | 12.2B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Appoints COO; Shares Rise 4%